Dr Shapiro, lead investigator of clinical trial at Dana Farber has a passion for the p53 and p21 science. He has published numerous papers and made a number of presentations dating back to at least 2002 that I can find.

Here is one abstract: http://cancerres.aacrjournals.org/content/66/15/7668.long

This gives me even more confidence ( not that I needed any) . . . he is not a "Geoffrey" come lately . . . this has been his passion, and Kevetrin may be the fulfillment of his dream! We are talking about one of the leading researchers of our time.He saw something in Kevetrin's MOA to want to clinical trial the drug . . . that's impressive..... and, promising.